Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AFL logo AFL
Upturn stock rating
AFL logo

Aflac Incorporated (AFL)

Upturn stock rating
$109.81
Last Close (24-hour delay)
Profit since last BUY3.29%
upturn advisory
Consider higher Upturn Star rating
BUY since 41 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: AFL (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

13 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $110

1 Year Target Price $110

Analysts Price Target For last 52 week
$110 Target price
52w Low $96.14
Current$109.81
52w High $113.9

Analysis of Past Performance

Type Stock
Historic Profit 8.21%
Avg. Invested days 51
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 57.61B USD
Price to earnings Ratio 24.26
1Y Target Price 110
Price to earnings Ratio 24.26
1Y Target Price 110
Volume (30-day avg) 13
Beta 0.85
52 Weeks Range 96.14 - 113.90
Updated Date 10/17/2025
52 Weeks Range 96.14 - 113.90
Updated Date 10/17/2025
Dividends yield (FY) 2.02%
Basic EPS (TTM) 4.44

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 15.32%
Operating Margin (TTM) 21.01%

Management Effectiveness

Return on Assets (TTM) 1.73%
Return on Equity (TTM) 9.15%

Valuation

Trailing PE 24.26
Forward PE 15.2
Enterprise Value 66887362794
Price to Sales(TTM) 3.62
Enterprise Value 66887362794
Price to Sales(TTM) 3.62
Enterprise Value to Revenue 4.13
Enterprise Value to EBITDA -
Shares Outstanding 534831490
Shares Floating 530189153
Shares Outstanding 534831490
Shares Floating 530189153
Percent Insiders 10.54
Percent Institutions 59.6

ai summary icon Upturn AI SWOT

Aflac Incorporated

stock logo

Company Overview

overview logo History and Background

Aflac Incorporated was founded in 1955 by brothers John and Paul Amos. Initially known as American Family Life Assurance Company, it focused on selling cancer insurance. Over time, Aflac expanded its product offerings and geographic reach, becoming a leading provider of supplemental insurance in the U.S. and Japan.

business area logo Core Business Areas

  • Aflac U.S.: Provides supplemental health and life insurance products to individuals and groups in the United States.
  • Aflac Japan: Offers supplemental insurance products, primarily cancer, medical, and income support policies, in Japan. This remains Aflac's largest market.

leadership logo Leadership and Structure

Aflac Incorporated is led by Daniel P. Amos (Chairman and CEO). The organizational structure includes various executive officers overseeing key functions such as finance, legal, sales, and marketing. It operates with a board of directors responsible for corporate governance.

Top Products and Market Share

overview logo Key Offerings

  • Cancer Insurance: Provides cash benefits to help with the costs associated with cancer treatment. Aflac has a strong market share in this area, particularly in Japan. Competitors include Cigna, MetLife, and other providers of supplemental insurance. The revenue earned from this product is a significant portion of Aflac's total revenue.
  • Accident Insurance: Offers cash benefits to help with unexpected medical expenses and other costs related to accidental injuries. Competitors include Colonial Life, Unum, and other providers of accident insurance. Market share is moderate in the US market, the number of users are in the millions.
  • Critical Illness Insurance: Provides a lump-sum payment upon diagnosis of a covered critical illness. Competitors include Transamerica, Mutual of Omaha, and other providers of critical illness insurance. Market share is moderate.
  • Hospital Indemnity Insurance: Pays benefits to help cover expenses associated with a hospital stay. This is Aflac's fastest growing product offering. Aflac is working to expand this coverage and get more members signed up.

Market Dynamics

industry overview logo Industry Overview

The supplemental insurance industry is characterized by increasing demand due to rising healthcare costs and gaps in traditional health insurance coverage. Growth is also driven by an aging population and a greater awareness of financial risks associated with illness and accidents.

Positioning

Aflac is a leading provider of supplemental insurance, particularly known for its brand recognition and strong presence in Japan. Its competitive advantages include a well-established distribution network, a focus on customer service, and innovative product offerings.

Total Addressable Market (TAM)

The global supplemental health insurance market is projected to reach several hundred billion USD. Aflac is positioned to capture a significant portion of this market, particularly in the US and Japan, by leveraging its brand recognition, distribution network, and expanding product portfolio.

Upturn SWOT Analysis

Strengths

  • Strong Brand Recognition
  • Large Distribution Network (especially in Japan)
  • High Customer Retention Rates
  • Financial Stability
  • Focus on Supplemental Insurance Niche

Weaknesses

  • Concentration of Revenue in Japan
  • Exposure to Foreign Exchange Rate Fluctuations
  • Dependence on Broker Distribution Channels
  • Competition in the U.S. Market

Opportunities

  • Expanding Product Offerings (e.g., dental, vision)
  • Growing Market for Supplemental Insurance in the U.S.
  • Strategic Acquisitions
  • Technological Innovations (e.g., digital sales platforms)

Threats

  • Changes in Healthcare Regulations
  • Increased Competition
  • Economic Downturns
  • Interest Rate Risk
  • Negative Publicity or Litigation

Competitors and Market Share

competitor logo Key Competitors

  • MetLife (MET)
  • Cigna (CI)
  • Unum Group (UNM)

Competitive Landscape

Aflac benefits from strong brand recognition and large network, especially in Japan, however Metlife and Cigna have a larger more diverse product offering and a larger presence within the healthcare industry.

Major Acquisitions

Zurich North Americau2019s Group Life and Pensions Business

  • Year: 2020
  • Acquisition Price (USD millions): 500
  • Strategic Rationale: Expanded Aflac's product portfolio in the U.S. market and enhanced its ability to serve larger employer groups.

Growth Trajectory and Initiatives

Historical Growth: Aflac has experienced steady growth over the past decade, driven by expansion in both the U.S. and Japan. Growth rates have been moderate, reflecting the mature nature of the supplemental insurance market.

Future Projections: Analysts project continued growth for Aflac, driven by an aging population and increased demand for supplemental insurance. Revenue growth is expected to be in the low to mid-single digits annually. This growth is coming from digital sales strategies.

Recent Initiatives: Recent strategic initiatives include expanding product offerings, investing in digital sales platforms, and pursuing strategic acquisitions to enhance market presence.

Summary

Aflac Incorporated is a strong company with a leading position in the supplemental insurance market, especially in Japan. Its brand recognition, financial stability, and commitment to shareholder returns are notable strengths. The company faces challenges related to its dependence on Japan, foreign exchange risks, and growing competition, which should be monitored closely as they expand their product offerings and market reach. They are growing and expanding into new regions and are expected to see positive returns over the next few years.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Aflac Incorporated Investor Relations
  • SEC Filings
  • Market Research Reports
  • Analyst Estimates

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market conditions and company performance can change rapidly, and past performance is not indicative of future results.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aflac Incorporated

Exchange NYSE
Headquaters Columbus, GA, United States
IPO Launch date 1984-07-19
Chairman & CEO Mr. Daniel Paul Amos
Sector Financial Services
Industry Insurance - Life
Full time employees 12694
Full time employees 12694

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.